Mohamed N. Malash

Mohamed N. Malash

Auto-generated profile, based on publicly available information

Mohamed N. Malash

Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University (ACU), Giza, Egypt

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
LZLaila Ziko
Laila Ziko
MAMustafa Adel
Mustafa Adel
MMMohamed N. Malash
Mohamed N. Malash
RSRania Siam
Rania Siam
The recent rise in antibiotic and chemotherapeutic resistance necessitates the search for novel drugs. Potential therapeutics can be produced by specialized metabolism gene clusters (SMGCs). We mined for SMGCs in metagenomic samples from Atlantis II Deep, Discovery Deep and Kebrit Deep Red Sea brine pools. Shotgun sequence assembly and secondary metabolite analysis shell (antiSMASH) screening unraveled 2751 Red Sea brine SMGCs, pertaining to 28 classes. Predicted categorization of the SMGC products included those (1) commonly abundant in microbes (saccharides, fatty acids, aryl polyenes, acyl-homoserine lactones), (2) with antibacterial and/or anticancer effects (terpenes, ribosomal peptides, non-ribosomal peptides, polyketides, phosphonates) and (3) with miscellaneous roles conferring adaptation to the environment/special structure/unknown function (polyunsaturated fatty acids, ectoine, ladderane, others). Saccharide (80.49%) and putative (7.46%) SMGCs were the most abundant. Selected Red Sea brine pool sites had distinct SMGC profiles, e.g., for bacteriocins and ectoine. Top promising candidates, SMs with pharmaceutical applications, were addressed. Prolific SM-producing phyla (Proteobacteria, Actinobacteria, Cyanobacteria), were ubiquitously detected. Sites harboring the largest numbers of bacterial and archaeal phyla, had the most SMGCs. Our results suggest that the Red Sea brine niche constitutes a rich biological mine, with the predicted SMs aiding extremophile survival and adaptation.

10 March 2015 in Food Analytical Methods
Verified
Journal Article
Closed access
PDF file
AMAdel M. Michael
Adel M. Michael
MMMohamed N. Malash
Mohamed N. Malash

4 January 2025 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
MHMervat Gameel Hassan
Mervat Gameel Hassan
GEGharieb El-Sayyad
Gharieb El-Sayyad
MAMohamed O. Abdel-Monem
Mohamed O. Abdel-Monem
MMMohamed N. Malash
Mohamed N. Malash
MKMona A. Kishk
Mona A. Kishk
MEMohamed I. El-Khonezy
Mohamed I. El-Khonezy
Background: Actinomycetes are a well-known example of a microbiological origin that may generate a wide variety of chemical structures. As excellent cell factories, these sources are able to manufacture medicines, agrochemicals, and enzymes that are crucial. Results: In this study, about 34 randomly selected Streptomyces isolates were discovered in soil, sediment, sea water, and other environments. Using a qualitative fast plate assay, they were tested for L-glutaminase production, and nine of them produced a significant amount of pink L-glutamine. Streptomyces sp. strain 5 M was identified by examining the 16S rRNA gene in the promising strain G8. A pH of 7.5, an incubation temperature of 40 °C, and the use of glucose and peptone as the carbon and nitrogen sources, respectively, produced the highest quantities of L-glutaminase. The molecular weight of the isolated L-glutaminase was estimated to be 52 kDa using SDS-PAGE analysis. At pH 7.5 and Temp., 40 °C, the isolated enzyme exhibited its highest levels of stability and activity. The isolated enzyme’s Km and Vmax values were 2.62 mM and 10.20 U/ml, respectively. Strong toxicity against HepG-2, HeLa, and MCF-7 was observed due to the anticancer properties of the isolated L-glutaminase. Conclusion: Our findings include the discovery of Streptomyces sp. strain 5 M, which yields a free L-glutaminase and maybe a possible applicant for extra pharmacological investigation as an antineoplastic drug.

1 May 2020 in Protein Expression and Purification
Verified
Journal Article
Closed access
MMMohamed N. Malash
Mohamed N. Malash
NHNahla A. Hussein
Nahla A. Hussein
SMShaden Muawia
Shaden Muawia
MNMahmoud I. Nasr
Mahmoud I. Nasr
RSRania Siam
Rania Siam